GERMANY-HEALTH-VIRUS-BIONTECH-VACCINES
Employees in cleanroom suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine at the new manufacturing site of German company BioNTech on March 27, 2021 in Marburg, central Germany. - German firm BioNTech said on March 30, 2021 it was on track to manufacture 2.5 billion doses of its Covid-19 vaccine this year with US partner Pfizer, 25 percent more than previously expected. (Photo by Thomas Lohnes / AFP) (Photo by THOMAS LOHNES/AFP via Getty Images)
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesGERMANY-HEALTH-VIRUS-BIONTECH-VACCINES, News PhotoGERMANY-HEALTH-VIRUS-BIONTECH-VACCINES Get premium, high resolution news photos at Getty ImagesProduct #:1232019283
$499$175
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.“The erroneous mention[s] appearing in the metadata of this photo by Thomas Lohnes has been modified in AFP systems in the following manner: [embargo is March 31, 00:01] instead of [April 1, 00:01].
Credit:
Editorial #:
1232019283
Collection:
AFP
Date created:
March 27, 2021
Upload date:
License type:
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_96W2UC
Max file size:
6048 x 4024 px (20.16 x 13.41 in) - 300 dpi - 7 MB
- BioNTech,
- Business,
- Business Finance and Industry,
- COVID-19,
- COVID-19 Vaccine,
- Chemical,
- Cleanroom,
- Delivery Person,
- Dose,
- Economy,
- Employee,
- Epidemic,
- Essential Services,
- Finance and Economy,
- Germany,
- Healthcare And Medicine,
- Hesse - Germany,
- Illness,
- Industry,
- Manufacturing,
- New,
- Pandemic - Illness,
- Percentage Sign,
- Pfizer,
- RNA,
- Science,
- Stability,
- Vaccination,
- Virus,